Iovance Biotherapeutics, Inc. (IOVA) vs Kodiak Sciences Inc. (KOD)

A side-by-side comparison of Iovance Biotherapeutics, Inc. and Kodiak Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IOVA vs KOD

growth of $100 · dividends reinvested · last 8y
IOVA +19.6% (+2.3%/yr)KOD +4521.2% (+61.5%/yr)KOD compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $1002020202220242026$120$4,621
IOVA KOD

IOVA vs KOD: by the numbers

  • •IOVA is the larger company ($5.85B vs $5.84B market cap).
  • •Both run net losses; KOD's is the smaller (0.00% vs -89.09% net margin).

Metrics side by side

Valuation

MetricIOVAKOD
P/S ratio18.01N/A
P/B ratio7.9595.57

Profitability

MetricIOVAKOD
Gross margin97.23%0.00%
Operating margin-153.08%0.00%
Net margin-89.09%0.00%
ROE-39.33%-396.09%
ROIC-37.26%-115.23%

Growth (annualized)

MetricIOVAKOD
Total return CAGR (5Y)-11.55%36.19%

Frequently asked

How have IOVA and KOD total returns compared?
Over the past 5 years, IOVA delivered -11.55% and KOD delivered 36.19% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.